tradingkey.logo
tradingkey.logo
Search

Rockwell Medical Inc

RMTI
Add to Watchlist
5.190USD
+4.639+842.78%
Close 07/01, 16:00ETQuotes delayed by 15 min
204.85MMarket Cap
LossP/E TTM

TradingKey Stock Score of Rockwell Medical Inc

Currency: USD Updated: 2026-07-01

Key Insights

Rockwell Medical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 67 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Rockwell Medical Inc's Score

Industry at a Glance

Industry Ranking
67 / 157
Overall Ranking
173 / 4564
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Rockwell Medical Inc Highlights

StrengthsRisks
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Growing
The company is in a growing phase, with the latest annual income totaling USD 69.26M.
Undervalued
The company’s latest PE is -35.00, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.15M shares, decreasing 29.95% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
30.000
Target Price
+5349.59%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Rockwell Medical Inc?

The TradingKey Stock Score provides a comprehensive assessment of Rockwell Medical Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Rockwell Medical Inc’s performance and outlook.

How do we generate the financial health score of Rockwell Medical Inc?

To generate the financial health score of Rockwell Medical Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Rockwell Medical Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Rockwell Medical Inc.

How do we generate the company valuation score of Rockwell Medical Inc?

To generate the company valuation score of Rockwell Medical Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Rockwell Medical Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Rockwell Medical Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Rockwell Medical Inc.

How do we generate the earnings forecast score of Rockwell Medical Inc?

To calculate the earnings forecast score of Rockwell Medical Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Rockwell Medical Inc’s future.

How do we generate the price momentum score of Rockwell Medical Inc?

When generating the price momentum score for Rockwell Medical Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Rockwell Medical Inc’s prices. A higher score indicates a more stable short-term price trend for Rockwell Medical Inc.

How do we generate the institutional confidence score of Rockwell Medical Inc?

To generate the institutional confidence score of Rockwell Medical Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Rockwell Medical Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Rockwell Medical Inc.

How do we generate the risk management score of Rockwell Medical Inc?

To assess the risk management score of Rockwell Medical Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Rockwell Medical Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Rockwell Medical Inc.